National Health Investors Expected to Report Q1 Earnings Monday

National Health Investors (NHI) reported strong first quarter revenue that exceeded expectations, driven by early acquisitions and higher-than-anticipated collections, with executives expressing confidence in continued growth. The company maintains a robust dividend policy, recently declaring a $0.90 per share dividend for Q2, and has demonstrated 35 consecutive years of dividend payments, highlighting its commitment to shareholder returns. Analysts generally rate NHI as 'Outperform,' citing its solid financial performance, technical momentum, and positive earnings outlook, though they caution about potential risks from tenant financial health, regulatory changes, and broader economic factors. NHI’s diverse healthcare real estate portfolio and stable income stream make it attractive to investors seeking stability and income. Brokerages have recently raised target prices, and consensus estimates point to continued earnings growth, supporting management's guidance of 12% to 15% growth for the year. However, investors are advised to consider uncertainties that could impact future performance.